FDA Issues Safety Communication on Birth Control Pills Yaz, Yasmin and Other Drospirenone Pills
Ennis & Ennis, P.A. Explains the Risks Associated with Drospirenone-Containing Birth Control Pills (PRWEB) September 28, 2011 According to Ennis & Ennis, P.A., on September 26, 2011, the U.S. Food and Drug Administration (FDA) released a Safety Communication reporting that it “remained concerned” about the potential increased risk of blood clots associated with the use of drospirenone-containing birth control pills. http://www.fda.gov/Drugs/DrugSafety/ucm273021.htm Drospirenone is the synthetic progestin ingredient used in certain birth control pills such as Yaz, Yasmin, Safyal,
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4